Stephen Basso
Directeur Financier/CFO chez INNOVIVA, INC.
Postes actifs de Stephen Basso
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INNOVIVA, INC. | Directeur Financier/CFO | 21/08/2023 | - |
Historique de carrière de Stephen Basso
Anciens postes connus de Stephen Basso
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOZYME PHARMA, INC. | Comptroller/Controller/Auditor | 01/10/2017 | 14/05/2021 |
| Directeur Financier/CFO | 01/10/2017 | 14/05/2021 | |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2009 | 01/05/2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Directeur des opérations | - | - |
| Directeur Financier/CFO | - | - |
Formation de Stephen Basso
| Providence College | Undergraduate Degree |
| Boston College | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INOZYME PHARMA, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Health Technology |
- Bourse
- Insiders
- Stephen Basso
- Expérience